» Articles » PMID: 37372101

Prediction Model for Pre-Eclampsia Using Gestational-Age-Specific Serum Creatinine Distribution

Overview
Journal Biology (Basel)
Publisher MDPI
Specialty Biology
Date 2023 Jun 28
PMID 37372101
Authors
Affiliations
Soon will be listed here.
Abstract

Pre-eclampsia (PE) is a pregnancy-related disease, causing significant threats to both mothers and babies. Numerous studies have identified the association between PE and renal dysfunction. However, in clinical practice, kidney problems in pregnant women are often overlooked due to physiologic adaptations during pregnancy, including renal hyperfiltration. Recent studies have reported serum creatinine (SCr) level distribution based on gestational age (GA) and demonstrated that deviations from the expected patterns can predict adverse pregnancy outcomes, including PE. This study aimed to establish a PE prediction model using expert knowledge and by considering renal physiologic adaptation during pregnancy. This retrospective study included pregnant women who delivered at the Wonju Severance Christian Hospital. Input variables, such as age, gestational weeks, chronic diseases, and SCr levels, were used to establish the PE prediction model. By integrating SCr, GA, GA-specific SCr distribution, and quartile groups of GA-specific SCr (GAQ) were made. To provide generalized performance, a random sampling method was used. As a result, GAQ improved the predictive performance for any cases of PE and triple cases, including PE, preterm birth, and fetal growth restriction. We propose a prediction model for PE consolidating readily available clinical blood test information and pregnancy-related renal physiologic adaptations.

References
1.
Moon S, Jang J, Kim Y, Oh C . Development and validation of a new diabetes index for the risk classification of present and new-onset diabetes: multicohort study. Sci Rep. 2021; 11(1):15748. PMC: 8333254. DOI: 10.1038/s41598-021-95341-8. View

2.
LeCun Y, Bengio Y, Hinton G . Deep learning. Nature. 2015; 521(7553):436-44. DOI: 10.1038/nature14539. View

3.
Rolnik D, Wright D, Poon L, OGorman N, Syngelaki A, de Paco Matallana C . Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017; 377(7):613-622. DOI: 10.1056/NEJMoa1704559. View

4.
Park S, Lee S, Park J, Hong J, Chin H, Na K . Midterm eGFR and Adverse Pregnancy Outcomes: The Clinical Significance of Gestational Hyperfiltration. Clin J Am Soc Nephrol. 2017; 12(7):1048-1056. PMC: 5498359. DOI: 10.2215/CJN.12101116. View

5.
Michiels S, Koscielny S, Hill C . Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet. 2005; 365(9458):488-92. DOI: 10.1016/S0140-6736(05)17866-0. View